Clinical trials
Phase 3 Neoplasms by Site trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 7 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Steba Biotech S.A. | 3 |
| Sumitomo Pharma America, Inc. | 3 |
| Hoffmann-La Roche | 2 |
| Medical Enterprises Europe B.V. | 2 |
| Abbott | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Binghe Xu | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 34 |
| Neoplasms | 28 |
| Carcinoma | 9 |
| Urogenital Neoplasms | 9 |
| Breast Diseases | 8 |
| Breast Neoplasms | 8 |
| Digestive System Diseases | 8 |
| Digestive System Neoplasms | 8 |
| Neoplasm Metastasis | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.